Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Product Landscape, 2021

Published : Nov-2021

No. of Pages : 131

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Vagus Nerve Stimulators (VNS) Overview
3 Products under Development
3.1 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
3.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
3.3 Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
3.4 Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
3.5 Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
4 Vagus Nerve Stimulators (VNS) - Pipeline Products under Development by Companies
4.1 Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
4.2 Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
5 Vagus Nerve Stimulators (VNS) Companies and Product Overview
5.1 Adriakaim Inc Company Overview
5.1.1 Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Aucta Technologies Inc Company Overview
5.2.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cala Health Inc Company Overview
5.4.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 CerboMed GmbH Company Overview
5.5.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.6 Cyberonics Inc Company Overview
5.6.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 DuoCure Ltd. Company Overview
5.7.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.8 ElectroCore Inc Company Overview
5.8.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Evren Technologies, Inc. Company Overview
5.9.1 Evren Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.10 Flint Rehabilitation Company Overview
5.10.1 Flint Rehabilitation Pipeline Products & Ongoing Clinical Trials Overview
5.11 FRD Accel LLC Company Overview
5.11.1 FRD Accel LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 LivaNova PLC Company Overview
5.12.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medical University of South Carolina Company Overview
5.13.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
5.14 MicroTransponder Inc Company Overview
5.14.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Nemechek Technologies LLC Company Overview
5.15.1 Nemechek Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.16 Neuroloop Gmbh Company Overview
5.16.1 Neuroloop Gmbh Pipeline Products & Ongoing Clinical Trials Overview
5.17 Nexeon MedSystems Inc Company Overview
5.17.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Otto Bock HealthCare GmbH Company Overview
5.18.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.19 Parasym Ltd Company Overview
5.19.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.20 Pulsus Medical LLC (Inactive) Company Overview
5.20.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.21 Purdue University Company Overview
5.21.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.22 Setpoint Medical Corp Company Overview
5.22.1 Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Soterix Medical Inc Company Overview
5.23.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 SUNY Downstate Medical Center Company Overview
5.24.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
5.25 Synergia Medical SA Company Overview
5.25.1 Synergia Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.26 SzeleSTIM GmbH Company Overview
5.26.1 SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.27 The Feinstein Institute for Medical Research Company Overview
5.27.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
5.28 Trifectas Medical Corp. Company Overview
5.28.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
5.29 University of Alabama Company Overview
5.29.1 University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
5.30 University of Auckland Company Overview
5.30.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
5.31 University of Pittsburgh Company Overview
5.31.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
5.32 University of Wisconsin Madison Company Overview
5.32.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
6 Vagus Nerve Stimulators (VNS)- Recent Developments
6.1 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
6.2 Nov 04, 2021: electroCore Announces Third Quarter 2021 Financial Results
6.3 Nov 03, 2021: LivaNova Reports Third Quarter 2021 Results
6.4 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
6.5 Sep 30, 2021: electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference
6.6 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.7 Aug 05, 2021: electroCore Announces Second Quarter 2021 Financial Results
6.8 Jul 28, 2021: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Sharpsburg as Chief Financial Officer
6.9 Jul 13, 2021: electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance
6.10 Jun 22, 2021: Feinstein Institutes scientists observe vagus nerve stimulation effect on brain activity
6.11 May 27, 2021: Purdue University hires new chief information officer
6.12 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.13 Apr 29, 2021: electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6
6.14 Apr 19, 2021: Scientists develop long-term vagus nerve implant for bioelectronic medicine research
6.15 Mar 11, 2021: electroCore announces fourth quarter and full year 2020 financial results
6.16 Mar 04, 2021: electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11
6.17 Mar 03, 2021: electroCore to Participate at Two Upcoming Investor Conferences
6.18 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.19 Jan 20, 2021: LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results
6.20 Dec 04, 2020: LivaNova to host satellite symposium on advances in Neuromodulation at American Epilepsy Society AES2020 virtual event
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials
Vagus Nerve Stimulators (VNS) Companies - Pipeline Products by Stage of Development
Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Adriakaim Inc Pipeline Products & Ongoing Clinical Trials Overview
Vagus Nerve Stimulation Device - Product Status
Vagus Nerve Stimulation Device - Product Description
Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
DECIMA Device - Product Status
DECIMA Device - Product Description
Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
AMT System - Product Status
AMT System - Product Description
Vagus Nerve Stimulation (VNS) System - Product Status
Vagus Nerve Stimulation (VNS) System - Product Description
Boston Scientific Corp - Ongoing Clinical Trials Overview
Vagus Nerve Stimulation (VNS) System - Neural Cardiac Therapy for Heart Failure Study
Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Wearable Neuromodulation Device - Product Status
Wearable Neuromodulation Device - Product Description
CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
t-VNS - Dementia - Product Status
t-VNS - Dementia - Product Description
Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Nerve Wrap - Product Status
Nerve Wrap - Product Description
DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Intraluminal Implantable Device - Product Status
Intraluminal Implantable Device - Product Description
ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview
ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus - Product Status
ElectroCore RMS-1100 Resolution Motility System - Post-Operative Ileus - Product Description
GammaCore - Gastroparesis - Product Status
GammaCore - Gastroparesis - Product Description
GammaCore - Opioid Use Disorder - Product Status
GammaCore - Opioid Use Disorder - Product Description
GammaCore - Parkinsonian Gait - Product Status
GammaCore - Parkinsonian Gait - Product Description
GammaCore - Post-Traumatic Headache - Product Status
GammaCore - Post-Traumatic Headache - Product Description
GammaCore - Post-Traumatic Stress Disorder - Product Status
GammaCore - Post-Traumatic Stress Disorder - Product Description
Gammacore - Reactive Airway Disease - Product Status
Gammacore - Reactive Airway Disease - Product Description
GammaCore - Rheumatoid Arthritis - Product Status
GammaCore - Rheumatoid Arthritis - Product Description
GammaCore - Sjogren's Syndrome - Product Status
GammaCore - Sjogren's Syndrome - Product Description
GammaCore - Stroke - Product Status
GammaCore - Stroke - Product Description
GammaCore - Subarachnoid Hemorrhage - Product Status
GammaCore - Subarachnoid Hemorrhage - Product Description
GammaCore - Traumatic Brain Injury - Product Status
GammaCore - Traumatic Brain Injury - Product Description
GammaCore - Ulcerative Colitis - Product Status
GammaCore - Ulcerative Colitis - Product Description
GammaCore Sapphire - Post-Traumatic Headache - Product Status
GammaCore Sapphire - Post-Traumatic Headache - Product Description
GammaCore Sapphire CV - Product Status
GammaCore Sapphire CV - Product Description
Resolve Stimulator and Proximity Electrode - Product Status
Resolve Stimulator and Proximity Electrode - Product Description
ElectroCore Inc - Ongoing Clinical Trials Overview
GammaCore - Gastroparesis - Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders
GammaCore Sapphire CV - A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)
GammaCore Sapphire - Post-Traumatic Headache - A Randomized, Multi-center, Double-blind, Sham-controlled Study of GammaCore Sapphire for the Treatment of Patients with Post-traumatic Headache
GammaCore - Subarachnoid Hemorrhage - Safety and Efficacy of Non-invasive Vagus Nerve Stimulation in the Treatment of Headache in Subarachnoid Hemorrhage
GammaCore - Subarachnoid Hemorrhage - Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage: STORM
GammaCore - Opioid Use Disorder - Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
GammaCore - Traumatic Brain Injury - Non-Invasive Vagal Nerve Stimulation in Veterans with Mild Traumatic Brain Injury (mTBI)
Evren Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Phoenix Earbud Device - Product Status
Phoenix Earbud Device - Product Description
Flint Rehabilitation Pipeline Products & Ongoing Clinical Trials Overview
FitMi VNS System - Product Status
FitMi VNS System - Product Description
FRD Accel LLC Pipeline Products & Ongoing Clinical Trials Overview
BabyStrong TaVNS Bottle Feeding System - Product Status
BabyStrong TaVNS Bottle Feeding System - Product Description
LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Aspire NP - Product Status
Aspire NP - Product Description
Centro Generator - Product Status
Centro Generator - Product Description
CentroSR Generator - Product Status
CentroSR Generator - Product Description
EpiTrace - Product Status
EpiTrace - Product Description
Equilia - Product Status
Equilia - Product Description
Griffin - Pulse Generator - Product Status
Griffin - Pulse Generator - Product Description
Intense Neuromodulation System - Heart Failure - Product Status
Intense Neuromodulation System - Heart Failure - Product Description
Microburst VNS Stimulator - Product Status
Microburst VNS Stimulator - Product Description
PhoenixRF SR - Product Status
PhoenixRF SR - Product Description
VITARIA System - Chronic Heart Failure - Product Status
VITARIA System - Chronic Heart Failure - Product Description
WaveLink - Product Status
WaveLink - Product Description
LivaNova PLC - Ongoing Clinical Trials Overview
VITARIA System - Chronic Heart Failure - Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction
Microburst VNS Stimulator - Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy
Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - Product Status
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - Product Description
Medical University of South Carolina - Ongoing Clinical Trials Overview
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - BabyStrong taVNS-Paired Bottle Feeding to Improve Oral Feeding
BabyStrong Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) - Testing a Wearable Telemedicine-controllable taVNS Device for NeuroCovid Recovery and Rehab
MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview
SAINT System - Anxiety Disorders - Product Status
SAINT System - Anxiety Disorders - Product Description
SAINT System - Tinnitus - Product Status
SAINT System - Tinnitus - Product Description
Serenity System - Product Status
Serenity System - Product Description
Vivistim Device - Product Status
Vivistim Device - Product Description
MicroTransponder Inc - Ongoing Clinical Trials Overview
Vivistim Device - A Pivotal Randomized Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function after Stroke: VNS-REHAB
Vivistim Device - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function after Stroke (MicroTransponder's Vivistim System) - Study MT-St-02 - Stroke
Nemechek Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Vitality Smartcable - COVID-19 - Product Status
Vitality Smartcable - COVID-19 - Product Description
Neuroloop Gmbh Pipeline Products & Ongoing Clinical Trials Overview
Neurostimulation System - Product Status
Neurostimulation System - Product Description
Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Auricular Vagus Nerve Stimulator - Asthma - Product Status
Auricular Vagus Nerve Stimulator - Asthma - Product Description
aVNS Device - Product Status
aVNS Device - Product Description
Vagus Nerve Stimulator - Asthma - Product Status
Vagus Nerve Stimulator - Asthma - Product Description
Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Neuromodulation Device - Epilepsy - Product Status
Neuromodulation Device - Epilepsy - Product Description
Neuromodulation Device - Sleep Apnea - Product Status
Neuromodulation Device - Sleep Apnea - Product Description
Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview
Parasym Device - Product Status
Parasym Device - Product Description
Parasym Ltd - Ongoing Clinical Trials Overview
Parasym Device - Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
Parasym Device - The Effect of Different Low-level Tragus Stimulation Parameters on Autonomic Nervous System Function
Parasym Device - Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery: The TraP-AF Study
Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
VNS Device - Product Status
VNS Device - Product Description
Purdue University Pipeline Products & Ongoing Clinical Trials Overview
Bionode Device - Product Status
Bionode Device - Product Description
Setpoint Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Implantable Bioelectronic Devices - Product Status
Implantable Bioelectronic Devices - Product Description
Setpoint Medical Corp - Ongoing Clinical Trials Overview
Implantable Bioelectronic Devices - Long Term Extension Study of the Safety and Efficacy of Neurostimulation Using a Vagus Nerve Stimulation Device in Patients with Rheumatoid Arthritis
Implantable Bioelectronic Devices - US Pivotal Trial Evaluate the Safety and Efficacy of Bioelectronic Platform in Rheumatoid Arthritis Patients
Implantable Bioelectronic Devices - Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Device - Product Status
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Device - Product Description
Soterix Medical Inc - Ongoing Clinical Trials Overview
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) Device - Clinical Trial Evaluating the Efficacy of Home-based Auricular Vagus Nerve Stimulation (taVNS) in Post-COVID-19 Subjects
SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Vagus Nerve Stimulator - Ventricular Arrhythmia - Product Status
Vagus Nerve Stimulator - Ventricular Arrhythmia - Product Description
Synergia Medical SA Pipeline Products & Ongoing Clinical Trials Overview
NAO·VNS - Chronic Pain - Product Status
NAO·VNS - Chronic Pain - Product Description
NAO·VNS - Depression - Product Status
NAO·VNS - Depression - Product Description
NAO·VNS - Epilepsy - Product Status
NAO·VNS - Epilepsy - Product Description
NAO·VNS - Parkinson's Disease - Product Status
NAO·VNS - Parkinson's Disease - Product Description
NAO·VNS - Sleep Apnoea - Product Status
NAO·VNS - Sleep Apnoea - Product Description
SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview
AuriMod - Product Status
AuriMod - Product Description
SzeleSTIM GmbH - Ongoing Clinical Trials Overview
AuriMod - Personalized Auricular Vagus Nerve Stimulation in Patients with Intractable Chronic Low Back Pain: A Randomized Controlled Pilot Study
The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Bioelectronic Medicine Device - Heart Failure - Product Status
Bioelectronic Medicine Device - Heart Failure - Product Description
Bioelectronic Medicine Device - Lupus - Product Status
Bioelectronic Medicine Device - Lupus - Product Description
Bioelectronic Medicine Device - Obesity - Product Status
Bioelectronic Medicine Device - Obesity - Product Description
Bioelectronic Medicine Device - Pulmonary Hypertension - Product Status
Bioelectronic Medicine Device - Pulmonary Hypertension - Product Description
Neurochip - Product Status
Neurochip - Product Description
Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview
Neurostimulation Device - Stroke Recovery - Product Status
Neurostimulation Device - Stroke Recovery - Product Description
University of Alabama Pipeline Products & Ongoing Clinical Trials Overview
VNS Device - Depression - Product Status
VNS Device - Depression - Product Description
University of Auckland Pipeline Products & Ongoing Clinical Trials Overview
Electroceutical Device - Product Status
Electroceutical Device - Product Description
University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
Closed-Loop Neuroelectric Device - Product Status
Closed-Loop Neuroelectric Device - Product Description
University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview
Implantable Weight-Loss Device - Product Status
Implantable Weight-Loss Device - Product Description
Glossary

List of Figures
Vagus Nerve Stimulators (VNS) - Pipeline Products by Stage of Development
Vagus Nerve Stimulators (VNS) - Pipeline Products by Territory
Vagus Nerve Stimulators (VNS) - Pipeline Products by Regulatory Path
Vagus Nerve Stimulators (VNS) - Pipeline Products by Estimated Approval Date
Vagus Nerve Stimulators (VNS) - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Vagus Nerve Stimulators (VNS) - Medical Devices Pipeline Product Landscape, 2021

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027